Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Familial hypogammaglobulinemia with high RTE and naïve T lymphocytes.

Piscianz E, Conversano E, Bianco AM, Faletra F, Tommasini A, Valencic E.

Inflamm Res. 2019 Nov;68(11):901-904. doi: 10.1007/s00011-019-01277-1. Epub 2019 Aug 29.

PMID:
31468084
2.

Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency.

Valencic E, Piscianz E, Sirchia F, Tommasini A, Faletra F, Todaro F, Spinelli AM, Badolato R.

Immunol Lett. 2019 Oct;214:52-54. doi: 10.1016/j.imlet.2019.08.003. Epub 2019 Aug 20. No abstract available.

PMID:
31442541
3.

Foxg1 Antagonizes Neocortical Stem Cell Progression to Astrogenesis.

Falcone C, Santo M, Liuzzi G, Cannizzaro N, Grudina C, Valencic E, Peruzzotti-Jametti L, Pluchino S, Mallamaci A.

Cereb Cortex. 2019 Mar 1. pii: bhz031. doi: 10.1093/cercor/bhz031. [Epub ahead of print]

PMID:
30821834
4.

Neuronal Dysfunction Associated with Cholesterol Deregulation.

Marcuzzi A, Loganes C, Valencic E, Piscianz E, Monasta L, Bilel S, Bortul R, Celeghini C, Zweyer M, Tommasini A.

Int J Mol Sci. 2018 May 19;19(5). pii: E1523. doi: 10.3390/ijms19051523.

5.

Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency.

Valencic E, Grasso AG, Conversano E, Lucafò M, Piscianz E, Gregori M, Conti F, Cancrini C, Tommasini A.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2165-2167. doi: 10.1016/j.jaip.2018.02.029. Epub 2018 Mar 3. No abstract available.

PMID:
29510232
6.

Low-dose sirolimus in two cousins with autoimmune lymphoproliferative syndrome-associated infection.

Nocerino A, Valencic E, Loganes C, Pelos G, Tommasini A.

Pediatr Int. 2018 Mar;60(3):315-317. doi: 10.1111/ped.13494. Epub 2018 Feb 26. No abstract available.

PMID:
29480551
7.

Type I interferon-mediated autoinflammation due to DNase II deficiency.

Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, Beitz B, Bondet V, Cagnard N, Duffy D, Dussiot M, Frémond ML, Gattorno M, Guillem F, Kitabayashi N, Porcheray F, Rieux-Laucat F, Seabra L, Uggenti C, Volpi S, Zeef LAH, Alyanakian MA, Beltrand J, Bianco AM, Boddaert N, Brouzes C, Candon S, Caorsi R, Charbit M, Fabre M, Faletra F, Girard M, Harroche A, Hartmann E, Lasne D, Marcuzzi A, Neven B, Nitschke P, Pascreau T, Pastore S, Picard C, Picco P, Piscianz E, Polak M, Quartier P, Rabant M, Stocco G, Taddio A, Uettwiller F, Valencic E, Vozzi D, Hartmann G, Barchet W, Hermine O, Bader-Meunier B, Tommasini A, Crow YJ.

Nat Commun. 2017 Dec 19;8(1):2176. doi: 10.1038/s41467-017-01932-3.

8.

The Challenge of Next Generation Sequencing in a Boy With Severe Mononucleosis and EBV-related Lymphoma.

Verzegnassi F, Valencic E, Kiren V, Giurici N, Bianco AM, Marcuzzi A, Vozzi D, Tommasini A, Faletra F.

J Pediatr Hematol Oncol. 2018 Jul;40(5):e323-e326. doi: 10.1097/MPH.0000000000001004.

PMID:
29176466
9.

Repositioning Drugs for Rare Immune Diseases: Hopes and Challenges for a Precision Medicine.

Valencic E, Smid A, Jakopin Z, Tommasini A, Mlinaric-Rascan I.

Curr Med Chem. 2018;25(24):2764-2782. doi: 10.2174/0929867324666170830101215. Review.

PMID:
28875839
10.

Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage.

Loganes C, Lega S, Bramuzzo M, Vecchi Brumatti L, Piscianz E, Valencic E, Tommasini A, Marcuzzi A.

Nutrients. 2017 Jun 6;9(6). pii: E578. doi: 10.3390/nu9060578.

11.

Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease.

Loganes C, Valencic E, Pin A, Marini E, Martelossi S, Naviglio S, De Leo L, Not T, Monasta L, Tommasini A, Marcuzzi A.

World J Gastroenterol. 2016 Nov 28;22(44):9734-9743.

12.

SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators.

Cason C, Campisciano G, Zanotta N, Valencic E, Delbue S, Bella R, Comar M.

J Cell Physiol. 2017 Nov;232(11):3060-3066. doi: 10.1002/jcp.25723. Epub 2016 Dec 29.

PMID:
27925194
13.

Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis.

Abate MV, Stocco G, Devescovi R, Carrozzi M, Pierobon C, Valencic E, Lucafò M, Di Silvestre A, D'Adamo P, Tommasini A, Decorti G, Ventura A.

Blood Cells Mol Dis. 2016 Jul;59:97-9. doi: 10.1016/j.bcmd.2016.05.001. Epub 2016 May 3. No abstract available.

PMID:
27282575
14.

Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes.

Piscianz E, Candilera V, Valencic E, Loganes C, Paron G, De Iudicibus S, Decorti G, Tommasini A.

Mol Med Rep. 2016 Jul;14(1):574-82. doi: 10.3892/mmr.2016.5263. Epub 2016 May 13.

PMID:
27175898
15.

To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies.

Marcuzzi A, Piscianz E, Valencic E, Monasta L, Vecchi Brumatti L, Tommasini A.

Int J Mol Sci. 2015 Sep 7;16(9):21277-93. doi: 10.3390/ijms160921277. Review.

16.

Alendronate, a double-edged sword acting in the mevalonate pathway.

Tricarico PM, Girardelli M, Kleiner G, Knowles A, Valencic E, Crovella S, Marcuzzi A.

Mol Med Rep. 2015 Sep;12(3):4238-4242. doi: 10.3892/mmr.2015.3957. Epub 2015 Jun 18.

17.

Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype.

Lougaris V, Faletra F, Lanzi G, Vozzi D, Marcuzzi A, Valencic E, Piscianz E, Bianco A, Girardelli M, Baronio M, Loganes C, Fasth A, Salvini F, Trizzino A, Moratto D, Facchetti F, Giliani S, Plebani A, Tommasini A.

Clin Immunol. 2015 Jul;159(1):33-6. doi: 10.1016/j.clim.2015.04.014. Epub 2015 May 1. No abstract available.

PMID:
25939554
18.

Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.

Taddio A, Tommasini A, Valencic E, Biagi E, Decorti G, De Iudicibus S, Cuzzoni E, Gaipa G, Badolato R, Prandini A, Biondi A, Ventura A.

World J Gastroenterol. 2015 Apr 14;21(14):4379-84. doi: 10.3748/wjg.v21.i14.4379.

19.

Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.

Frausin S, Viventi S, Verga Falzacappa L, Quattromani MJ, Leanza G, Tommasini A, Valencic E.

Acta Histochem. 2015 May-Jun;117(4-5):329-38. doi: 10.1016/j.acthis.2015.02.005. Epub 2015 Mar 4. Review.

PMID:
25747736
20.

Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds.

Tricarico PM, Kleiner G, Valencic E, Campisciano G, Girardelli M, Crovella S, Knowles A, Marcuzzi A.

Int J Mol Sci. 2014 Apr 22;15(4):6843-56. doi: 10.3390/ijms15046843.

Supplemental Content

Loading ...
Support Center